Health TrialsbyHealthPanel

Efficiency of Asiaticoside as Intracanal Medication in Revascularization Process

ConditionsImmature Permanent Teeth With Open ApexPulp Necrosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-18
SponsorMansoura University

About this trial

This study assess the ability of Asiaticoside based Intracanal medication compared to the commonly used Intracanal medicament ( calcium hydroxide Ca(OH) 2) on the outcome of the revascularization process in immature permanent teeth with pulp necrosis

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Both gender

patients having permanent anterior teeth with necrotic pulp and immature apex

Good general health

pulp space not needed for post and core

Disqualifiers

Radiographic identification of root fracture or abnormality

Uncooperative patients

Root resorption (internal or external)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Intracanal medication

    Procedure/Surgery

    Intracanal Medication for 3 weeks in Revascularization Process

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: AsiaticosideExperimental treatment 1 intervention
Group B: Calcium hydroxideExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Increase In Root Length

Radiographic increase in root length ( Millimeters(mm))

Time frame
12 monthsl
2

Increase In Dentinal Wall Thickness

Radiographic increase in dentinal wall thickness measured using digital image analysis (Millimeters(mm))

Time frame
12 months
3

Periapical Bone Formation

Radiographic evidence of periapical bone formation

Time frame
12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mansoura University

Lead sponsor

Source ClinicalTrials.gov
Apply now